Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: a protocol for a randomised controlled trial

INTRODUCTION: Acute kidney injury (AKI) is a common and severe clinical problem that is associated with high mortality, a long hospital stays and high healthcare resource consumption. Approximately a quarter of AKI survivors will develop chronic kidney disease. Mesenchymal stem cells (MSCs) are mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuanjun, Gao, Jianjun, Wang, Siyang, Wang, Wenjuan, Zhu, Fang-Lei, Wang, Xiaolong, Liang, Shuang, Feng, Zhe, Lin, Shupeng, Zhang, Li, Chen, Xiangmei, Cai, Guangyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862499/
https://www.ncbi.nlm.nih.gov/pubmed/35190406
http://dx.doi.org/10.1136/bmjopen-2020-047622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862499/
https://www.ncbi.nlm.nih.gov/pubmed/35190406
http://dx.doi.org/10.1136/bmjopen-2020-047622

Ejemplares similares